US-China rivalry in brain implants grows, with China advancing faster.
China leads BCI development and commercialization, a commission reports, and granted the approval believed to be first for restoring hand movement.
OriginalSourceAxiosUnited StatesLeanCenterCredibilityPublished09:30 UTCRatings: AllSides, MBFCSourceAxiosUnited StatesLeanCenterCredibilityPublished09:30 UTCRatings: AllSides, MBFC
“Brain implants fuel U.S.-China bioscience rivalry”
US-China rivalry in brain implants grows, with China advancing faster.
Key points
- National Security Commission reports China leads in brain-computer interface development and commercialization.
- BCIs show potential for stroke, Parkinson's, and other neurological conditions, per the analysis.
- China granted what is believed to be the first commercial BCI approval for restoring hand movement.
- US regulatory and funding bottlenecks threaten its BCI pipeline and innovation leadership.
- Recommendations call for clearer FDA pathways and CMS coverage for breakthrough brain implants.
How it got here
Axios publishes the article.
concise reads it.
The Brief ranks it 10th.
10 10 US-China rivalry in brain implants grows, with China advancing faster.
China leads BCI development and commercialization, a commission reports, and granted the approval believed to be first for restoring hand movement.